Safe Cardiometabolic Drug Prescribing to Prevent Injury in Nursing Home Residents
Description: Public Health Statement: Injurious falls and cardiometabolic disease are common and consequential for nursing home residents, particularly those with Alzheimer’s Disease and Related Disorders (ADRD). The purpose of this project is to determine the net clinical benefit of cardiometabolic drugs in ADRD and other nursing home residents. Our findings will be relevant to public health as they will inform clinical treatment of cardiometabolic disease, prevent injurious falls, and save costs in the nursing home.
Funder: National Institute on Aging
Funding type: research
Funder scheme: RF1
Start date: 2019-07-15
End date: 2024-07-15
Investigator: SARAH DYER BERRY (lead)
Institution: HEBREW REHABILITATION CENTER FOR AGED
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 45
Funder award ID: RF1AG061221
OpenAlex ID: G269004622
